A

Asahi Intecc Co Ltd
TSE:7747

Watchlist Manager
Asahi Intecc Co Ltd
TSE:7747
Watchlist
Price: 3 355 JPY 1.15% Market Closed
Market Cap: ¥890.2B

P/OCF

22
Current
5%
More Expensive
vs 3-y average of 20.9

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
22
=
Market Cap
¥865B
/
Operating Cash Flow
¥40.5B

Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.

P/OCF
22
=
Market Cap
¥865B
/
Operating Cash Flow
¥40.5B

Valuation Scenarios

Asahi Intecc Co Ltd is trading above its 3-year average

If P/OCF returns to its 3-Year Average (20.9), the stock would be worth ¥3 189.59 (5% downside from current price).

Statistics
Positive Scenarios
1/4
Maximum Downside
-48%
Maximum Upside
+65%
Average Downside
4%
Scenario P/OCF Value Implied Price Upside/Downside
Current Multiple 22 ¥3 355
0%
3-Year Average 20.9 ¥3 189.59
-5%
5-Year Average 36.4 ¥5 551.55
+65%
Industry Average 15.3 ¥2 339.57
-30%
Country Average 11.5 ¥1 747.89
-48%

Forward P/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward P/OCF

Peer Comparison

All Multiples
P/OCF
P/E
All Countries
Close
Market Cap P/OCF P/E
JP
Asahi Intecc Co Ltd
TSE:7747
890.2B JPY 22 50.3
US
Medline Inc
NASDAQ:MDLN
58.8B USD 0 0
JP
Hoya Corp
TSE:7741
9.7T JPY 38.4 38.6
CH
Alcon AG
SIX:ALC
29.2B CHF 16.1 37.3
DK
Coloplast A/S
CSE:COLO B
94.7B DKK 13.7 23.5
US
Align Technology Inc
NASDAQ:ALGN
13.5B USD 22.8 33
UK
ConvaTec Group PLC
LSE:CTEC
4.3B GBP 12.2 32.7
CA
Bausch + Lomb Corp
NYSE:BLCO
5.6B USD 19.7 -15.5
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
36.7B CNY 26.3 23.3
KR
HLB Inc
KOSDAQ:028300
8T KRW -86.1 -36.2
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.4B USD 14 23.3
P/E Multiple
Earnings Growth PEG
JP
A
Asahi Intecc Co Ltd
TSE:7747
Average P/E: 32.8
50.3
40%
1.3
US
M
Medline Inc
NASDAQ:MDLN
Not Available
30%
N/A
JP
Hoya Corp
TSE:7741
38.6
15%
2.6
CH
Alcon AG
SIX:ALC
37.3
32%
1.2
DK
Coloplast A/S
CSE:COLO B
23.5
21%
1.1
US
Align Technology Inc
NASDAQ:ALGN
33
34%
1
UK
ConvaTec Group PLC
LSE:CTEC
32.7
41%
0.8
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -15.5 N/A N/A
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
23.3
9%
2.6
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -36.2 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
23.3
30%
0.8

Market Distribution

Higher than 83% of companies in Japan
Percentile
83nd
Based on 4 634 companies
83nd percentile
22
Low
0.1 — 8
Typical Range
8 — 16
High
16 —
Distribution Statistics
Japan
Min 0.1
30th Percentile 8
Median 11.5
70th Percentile 16
Max 277 515 329.3

Asahi Intecc Co Ltd
Glance View

Market Cap
890.2B JPY
Industry
Health Care

Asahi Intecc Co., Ltd. stands at the intersection of precision engineering and medical innovation, carving a niche in the specialized realm of guide wires and catheters, essential tools in the field of cardiovascular interventions. The company, rooted in Japan, has harnessed its expertise in ultra-fine stainless steel wire ropes—a technology initially honed for industrial purposes—to revolutionize medical devices. Unlike many in the industry, Asahi Intecc integrates its manufacturing vertically, producing components in-house to maintain high standards of quality and performance. This meticulous approach ensures that its products meet the demanding specifications of the medical community. Beyond its cornerstone medical division, the company extends its reach into industrial fields such as robotics and consumer electronics, where its high-precision capabilities are equally prized. The financial scaffolding of Asahi Intecc is built on its ability to consistently deliver innovative solutions that address the needs of an aging global population increasingly susceptible to cardiovascular ailments. Its robust R&D initiatives are pivotal in sustaining its competitive edge, fostering the development of next-generation medical devices that cater to the complex demands of advanced medical procedures. The company capitalizes on a global distribution network, allowing it to tap into burgeoning markets across Asia, Europe, and the Americas. Revenue streams are diversified across product sales, royalties, and collaborative ventures, with significant investments channeled back into research, ensuring that Asahi Intecc maintains a cycle of continuous improvement and adaptation in the fast-evolving med-tech landscape.

Intrinsic Value
2 291.61 JPY
Overvaluation 32%
Intrinsic Value
Price ¥3 355
A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett